医学
精密医学
重症监护医学
心脏病学
内科学
病理
作者
John R. Giudicessi,Michael J. Ackerman,Diane Fatkin,Jason C. Kovacic
标识
DOI:10.1016/j.jacc.2021.03.325
摘要
In the initial 3 papers in this Focus Seminar series, the fundamentals and key concepts of precision medicine were reviewed, followed by a focus on precision medicine in the context of vascular disease and cardiomyopathy. For the remaining 2 papers, we focus on precision medicine in the context of arrhythmias. Specifically, in this fourth paper we focus on long QT syndrome, Brugada syndrome, and atrial fibrillation. The final (fifth) paper will deal with catecholaminergic polymorphic ventricular tachycardia. These arrhythmias represent a spectrum of disease ranging from common to relatively rare, with very different genetic and environmental causative factors, and with differing clinical manifestations that range from almost no consequences to lethality in childhood or adolescence if untreated. Accordingly, the emerging precision medicine approaches to these arrhythmias vary significantly, but several common themes include increased use of genetic testing, avoidance of triggers, and personalized risk stratification to guide the use of arrhythmia-specific therapies. • Diverse genetic and environmental factors may contribute to the genesis of cardiac arrhythmias. • Precision medicine approaches hold significant promise to enhance the diagnosis and treatment of potentially lethal cardiac arrhythmias. • Genetic testing, delineation of avoidable triggers, and risk stratification can be deployed to individualize specific antiarrhythmic therapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI